Empirical Antifungal Therapy in Febrile Neutropenic Patients: Caution about Composite End Points and the Perils ofPValues

Open Access

1 December 2004

journal article
Published by Oxford University Press (OUP) in Clinical Infectious Diseases

Vol. 39 (11) , 1738-1739
https://doi.org/10.1086/425922

Abstract

Lastly, one cannot consider the components of the composite end point in isolation. This is part of the reason for having a composite end point [6]. One cannot

Keywords

FEBRILE NEUTROPENIC
NEUTROPENIC PATIENTS
TREATMENT
PROPHYLAXIS
POINTS
FUNGAL INFECTIONS
DIFFERENTIATE

This publication has 1 reference indexed in Scilit:

Statistics notes: Multiple significance tests: the Bonferroni method
BMJ, 1995